Report Overview
The Europe Ultrasound Devices Market size was valued at US$ 2.57 billion in 2025 and is forecast to reach US$ 4.29 billion by 2035, growing at a CAGR of 5.26% during the forecast period 2026-2035.
An ultrasound device employs high-frequency sound waves to see the body's interior organs. An ultrasound system includes a probe that sends high-frequency ultrasonic sound waves into the patient's body. The bodily organs then reflect these sound waves into the probe.
These transmitted waves are subsequently sent to a display system, which creates the picture via echoes. Ultrasound devices are used to see organs such as the liver, kidneys, blood arteries, heart, human fetus, and others.
Market Scope
| Metrics | Details |
| CAGR | 6.9% |
| Market Size Available for Years | 2025-2035 |
| Estimation Forecast Period | 2026-2035 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Type, Technology, Application, End-User |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Rising prevalence of chronic diseases
Chronic disorders such as cardiovascular disease, and cancer among others often require ongoing monitoring and diagnostic imaging to treat and monitor the progression of the disease. Ultrasound devices are commonly utilized for these reasons as they are non-invasive and can provide real-time imaging.
Ultrasound devices are a vital diagnostic tool for conditions such as cancer and cardiovascular disease. The growing incidence of chronic illnesses in the European Union is expected to fuel demand and provide a market opportunity for these devices.
For instance, according to the European Heart Journal by Oxford University Press in 2024, it is stated that cardiovascular diseases account for 11% of the EU's total healthcare expenditure. It remains the most common cause of death in ESC member countries with over 3 million deaths per year.
Cardiology ultrasounds can detect issues with heart valves, such as stenosis or mitral or tricuspid regurgitation. These abnormalities can disrupt normal blood flow and lead to serious health problems if left untreated. Thus, the above factors are expected to drive market growth during the forecast period.
Additionally, to enhance device performance in urgent and emergency medical applications, producers of medical ultrasound devices in the EU market use wireless technologies like Bluetooth and near-field communication.
High costs of advanced ultrasound devices
Apart from the initial cost of purchase, advanced ultrasound machines frequently face additional operational and maintenance expenditures. These factors can discourage healthcare providers from investing in new technology. Hospitals and clinics have limited funds and may prioritize expenditure on other areas, such as essential or critical needs. The high cost of the latest ultrasound devices can result in a reduced allocation of funds to these technologies.
Market Segment Analysis
The Europe ultrasound devices market is segmented based on type, technology, application, and end-user.
The portable ultrasound segment is expected to dominate the market share
Portable ultrasound devices hold a significant portion of the market share and are expected to continue throughout the forecast period. This is due to the increasing adoption of portable devices by healthcare providers due to their efficiency and the comfort associated with the devices. Portable ultrasonography has several uses in emergency departments, point-of-care, and at home.
Hospitals and other healthcare practitioners are using handheld ultrasound imaging equipment owing to their simplicity of use and accuracy. These devices have more demand in emergency and anesthesia departments. With advances in technology, manufacturers are making devices smaller and more portable and adding 3D and 4D imaging.
For instance, on August 27, 2024, GE HealthCare received European approval for two cardiac imaging devices that include a wireless handheld ultrasound and a device capable of running a CT scan without a patient's electrocardiogram signal.
Additionally, in January 2024, Clarius launched the CE-marked PAL HD3 ultrasound scanner in the European Union and the UK. The Claruis’ handheld device can provide high-resolution images up to 40 cm in depth from the skin surface.
Thus, introducing advanced portable ultrasound devices into the market and the efficiency maintained by these devices is expected to drive the segment’s growth and expected to hold the dominant position.
Market Segmentation
By Type
- Stationary Ultrasound
- Portable Ultrasound
By Technology
- 2D Ultrasound Imaging
- 3D and 4D Ultrasound Imaging
- Doppler Imaging
- High-intensity Focused Ultrasound
By Application
- Anesthesiology
- Cardiology
- Gynecology/Obstetrics
- Musculoskeletal
- Radiology
- Critical Care
- Other
By End-User
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Others
Market Competitive Landscape
The major players in the market include GE Healthcare, Siemens Healthineers AG, Philips Healthcare Europe, Canon Medical Systems Europe BV, Samsung Medison Europe, FUJIFILM Europe GmbH, Esaote SpA, Mindray Europe, SternMed GmbH and 4medic GmbH among others.
Geography Analysis
Western Europe: Germany, France, the UK and Italy remain important markets because of established hospital infrastructure, advanced diagnostic imaging capabilities and continued replacement of installed ultrasound systems. The region is also moving toward AI-enabled ultrasound workflows, with Philips launching its Alturion system in Europe in 2026 and expanding automated measurement capabilities.
Southern Europe: Spain and Italy are seeing increasing opportunities from modernization of diagnostic services and wider use of ultrasound across hospitals and outpatient settings. Spain, in particular, can benefit from investments aimed at improving access to diagnostic services outside major urban centers.
Northern Europe: Nordic countries continue to emphasize digitally connected healthcare, efficient diagnostic workflows and technology integration. The European push toward AI-supported medical imaging is also creating opportunities for ultrasound systems that can integrate automated analysis into clinical workflows.
Eastern Europe: Eastern European markets present longer-term expansion opportunities as healthcare facilities modernize diagnostic equipment and improve access to imaging services. Adoption is likely to remain more price-sensitive than in Western Europe, increasing demand for portable, efficient and scalable ultrasound platforms.
Recent Developments
- Philips launches Alturion in Europe: In July 2026, Philips introduced the Alturion ultrasound system in Europe following CE marking. The platform combines AI-powered measurements, advanced imaging and a connected ecosystem for high-volume clinical environments.
- Philips expands AI-enabled ultrasound: In June 2026, Philips announced Elevate Plus for EPIQ Elite and Affiniti ultrasound systems, adding AI-powered measurement and workflow automation designed to improve consistency and reduce repeat scanning.
- Canon and Fraiya collaborate on prenatal ultrasound: In June 2026, Canon Medical Systems Europe and Fraiya announced a strategic collaboration combining Canon ultrasound platforms with AI-supported prenatal scanning, automated biometric measurements and scan-completeness guidance.
- AI moves deeper into prenatal imaging: The Canon–Fraiya collaboration initially targets selected European markets during 2026, highlighting increasing use of software-based automation in fetal anomaly examinations and prenatal screening workflows.
- EUDAMED becomes operationally important: From May 28, 2026, the EU UDI/Devices module became mandatory for applicable medical-device registrations, increasing the importance of device traceability and regulatory-data readiness for ultrasound manufacturers.
- Sustainability enters ultrasound product design: Canon's Aplio beyond, launched for selected markets, incorporates lower energy consumption, lighter construction and recyclable packaging, reflecting increasing attention to resource efficiency in medical imaging equipment.
- AI and portable ultrasound gain strategic importance: European manufacturers are increasingly combining automated measurements, connected workflows and compact system designs to support imaging outside traditional radiology departments, including outpatient and point-of-care environments.
Why Purchase the Report?
- To visualize the Europe ultrasound devices market segmentation based on type, technology, application, and end-user as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of ultrasound devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
